arrow
S

Sergi Clavé

institut hospital del mar d'investigacions mediques
H指数:13
被引数:517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study

免疫疗法治疗KRAS G12C突变与非G12C突变非小细胞肺癌的临床结局:一项多中心真实世界研究

2026-08-070
OAAI
Gene fusions in non-small cell lung carcinoma (NSCLC): Expert perspectives and practical considerations for routine testing

非小细胞肺癌(NSCLC)中的基因融合:专家观点和常规检测的实践考量

2026-07-010
OAAI
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade

接受免疫检查点阻断的转移性NSCLC患者的分子和免疫学特征与长期获益相关

2025-02-240
OA
RET Fusion Testing in Patients With NSCLC: The RETING Study
2024-04-012
OA
Spatial proteomic profiling unveils pre-existing anti-tumor immunity as a hallmark of exceptional benefit from immunotherapy in NSCLC
2024-03-220
PRE
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
2023-10-202
OAAI
Identifying long-term responders to immune checkpoint blockade: Potential utility of serum proteomic profiling in metastatic non-small cell lung cancer
2023-10-010
OAAI
Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung Cancer
2022-09-0113
OAAI